JPWO2019236879A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019236879A5
JPWO2019236879A5 JP2021518045A JP2021518045A JPWO2019236879A5 JP WO2019236879 A5 JPWO2019236879 A5 JP WO2019236879A5 JP 2021518045 A JP2021518045 A JP 2021518045A JP 2021518045 A JP2021518045 A JP 2021518045A JP WO2019236879 A5 JPWO2019236879 A5 JP WO2019236879A5
Authority
JP
Japan
Prior art keywords
compound according
teeth
halogen
och
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021518045A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021527125A5 (https=
JP2021527125A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/035833 external-priority patent/WO2019236879A1/en
Publication of JP2021527125A publication Critical patent/JP2021527125A/ja
Publication of JP2021527125A5 publication Critical patent/JP2021527125A5/ja
Publication of JPWO2019236879A5 publication Critical patent/JPWO2019236879A5/ja
Priority to JP2023203259A priority Critical patent/JP7576145B2/ja
Pending legal-status Critical Current

Links

JP2021518045A 2018-06-07 2019-06-06 Sarm1阻害剤 Pending JP2021527125A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023203259A JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862682033P 2018-06-07 2018-06-07
US62/682,033 2018-06-07
PCT/US2019/035833 WO2019236879A1 (en) 2018-06-07 2019-06-06 Inhibitors of sarm1

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023203259A Division JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Publications (3)

Publication Number Publication Date
JP2021527125A JP2021527125A (ja) 2021-10-11
JP2021527125A5 JP2021527125A5 (https=) 2022-06-22
JPWO2019236879A5 true JPWO2019236879A5 (https=) 2022-06-22

Family

ID=68769462

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021518045A Pending JP2021527125A (ja) 2018-06-07 2019-06-06 Sarm1阻害剤
JP2023203259A Active JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023203259A Active JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Country Status (8)

Country Link
US (1) US12338238B2 (https=)
EP (1) EP3801500B1 (https=)
JP (2) JP2021527125A (https=)
CN (1) CN112839647B (https=)
CA (1) CA3102645A1 (https=)
ES (1) ES3028093T3 (https=)
MA (1) MA52813A (https=)
WO (1) WO2019236879A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3028093T3 (en) 2018-06-07 2025-06-18 Disarm Therapeutics Inc Inhibitors of sarm1
US12448374B2 (en) 2018-06-07 2025-10-21 Disarm Therapeutics, Inc. Inhibitors of SARM1
WO2020132045A1 (en) 2018-12-19 2020-06-25 Disarm Therapeutics, Inc. Inhibitors of sarm1 in combination with neuroprotective agents
CA3141404A1 (en) 2019-06-14 2020-12-17 Disarm Therapeutics, Inc. Inhibitors of sarm1
JP7534390B2 (ja) 2019-09-12 2024-08-14 ディスアーム セラピューティクス, インコーポレイテッド Sarm1の阻害剤
EP4065714A1 (en) * 2019-11-26 2022-10-05 Disarm Therapeutics, Inc. Methods and compositions for neuroprotection
CN115916764B (zh) * 2020-04-09 2024-09-20 达萨玛治疗公司 作为sarm1抑制剂的吲唑衍生物
US12606558B2 (en) 2020-04-09 2026-04-21 Disarm Therapeutics, Inc. Condensed pyrazole derivatives as inhibitors of SARM1
IL298577A (en) * 2020-05-27 2023-01-01 Emendobio Inc Biallelic silencing of sarm1
TW202334117A (zh) 2020-08-24 2023-09-01 美商達薩瑪治療公司 Sarm1之抑制劑
EP4536637A2 (en) * 2022-06-06 2025-04-16 Nico Therapeutics, Inc. Compounds, compositions, and methods
WO2023244788A1 (en) * 2022-06-17 2023-12-21 Neuron23, Inc. Kinase modulators and methods of use thereof
JP2026503618A (ja) 2023-01-24 2026-01-29 ディスアーム セラピューティクス, インコーポレイテッド Sarm1阻害剤としての置換された1h-ピラゾール-4-カルボキサミド
TW202509019A (zh) * 2023-04-27 2025-03-01 香港商維泰瑞隆(香港)生物科技有限公司 Sarm1調節子、其製劑及用途

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1022214A (en) 1963-01-31 1966-03-09 Sterling Drug Inc Novel 1,3-disubstituted-1,4-dihydro-4-oxo-1,7-naphthyridines and their preparation
US3429887A (en) 1965-01-26 1969-02-25 Sterling Drug Inc 1,7-naphthyridine-3-carboxylic acid derivatives and their preparation
US3506668A (en) 1965-01-26 1970-04-14 Sterling Drug Inc Method of preparing 8-hydroxy-quinolines
US3429882A (en) 1968-03-25 1969-02-25 Geigy Chem Corp 1,2,8,9-tetraazaphenalenes
US3539567A (en) 1968-04-23 1970-11-10 Geigy Chem Corp 8-carboxy-1(2h) phthalazinones
US3624108A (en) 1968-04-23 1971-11-30 Geigy Chem Corp 7-carboxyphthalides
US3761493A (en) 1968-04-23 1973-09-25 Ciba Geigy Corp 3-dibromomethylphthalic anhydride
US3542777A (en) 1968-08-12 1970-11-24 Geigy Chem Corp Derivatives of 9-pyridylalkyl-1,2,8,9-tetraazaphenalenes
US3517014A (en) 1969-06-16 1970-06-23 Sterling Drug Inc Method of preparing 8-hydroxyquinoline-3-carboxylic acids
US3711473A (en) 1970-04-06 1973-01-16 Ciba Geigy Corp 3-hydrazino-1,2,8,9-tetraazaphenalenes
CA1043616A (en) 1973-10-16 1978-12-05 Fuji Photo Film Co. Heat developable light-sensitive material
US4207112A (en) 1974-01-29 1980-06-10 Fuji Photo Film Co., Ltd. Heat developable light-sensitive materials
JPS50123331A (https=) 1974-03-14 1975-09-27
GB9310700D0 (en) * 1993-05-24 1993-07-07 Zeneca Ltd Novel composition
HK1053833A1 (zh) 2000-04-27 2003-11-07 Abbott Laboratories 取代苯基法呢基转移酶抑制剂
CN100411686C (zh) 2001-04-11 2008-08-20 千寿制药株式会社 视觉功能障碍改善剂
ES2211344B1 (es) * 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
WO2005102345A1 (en) * 2004-03-30 2005-11-03 Alcon, Inc. Use of rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance
US20060078890A1 (en) * 2004-10-08 2006-04-13 Ole Isacson Methods for identifying parkinson's disease therapeutics
NZ565040A (en) * 2005-06-28 2010-05-28 Sanofi Aventis Isoquinoline derivatives as inhibitors of RHO-kinase
JP5049970B2 (ja) * 2005-07-26 2012-10-17 サノフイ Rho−キナーゼ阻害剤としてのシクロヘキシルアミンイソキノロン誘導体
EP1922311A2 (en) 2005-09-09 2008-05-21 Brystol-Myers Squibb Company Acyclic ikur inhibitors
GB0605766D0 (en) 2006-03-22 2006-05-03 Ucb Sa Process
WO2008001369A1 (en) * 2006-06-27 2008-01-03 Pharmos Corporation Use of cb2 receptor agonists for promoting neurogenesis
EP2043638A2 (en) 2006-07-13 2009-04-08 Novartis AG Use of trifluoromethyl substituted benzamides in the treatment of neurological disorders
JP5599783B2 (ja) * 2008-05-30 2014-10-01 アムジエン・インコーポレーテツド Pi3キナーゼの阻害薬
JP2010053073A (ja) * 2008-08-28 2010-03-11 Sankyo Kasei Kk ハロゲン化イソキノリン類の製造方法
MX2011008276A (es) * 2009-02-06 2011-12-14 Elan Pharm Inc Inhibidores de quinasa jun n-terminal.
WO2012106343A2 (en) * 2011-02-01 2012-08-09 The Board Of Trustees Of The University Of Illinois Hdac inhibitors and therapeutic methods using the same
DE102011009961A1 (de) * 2011-02-01 2012-08-02 Merck Patent Gmbh 7-Azaindolderivate
US20120328629A1 (en) 2011-06-24 2012-12-27 University Of Miami Therapeutic Applications Targeting SARM1
WO2013005157A1 (en) * 2011-07-05 2013-01-10 Lupin Limited Sulfone derivatives and their use as pkm2 modulators for the treatment of cancer
DE102012019369A1 (de) 2012-10-02 2014-04-03 Merck Patent Gmbh 7-Azaindolderivat
RS55943B1 (sr) 2013-06-24 2017-09-29 Merck Patent Gmbh Ftalazin derivati
WO2015050471A1 (en) * 2013-10-02 2015-04-09 Obschestvo S Ogranichennoy Otvetstvennost'yu "Panacela Labs" Carbazole compounds and methods of using same
WO2015102929A1 (en) * 2013-12-30 2015-07-09 Novartis Ag Tricyclic sulfonamide derivatives
FR3017868A1 (fr) * 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US9856264B2 (en) 2014-04-28 2018-01-02 Medshine Discovery Inc. Isoquinolinesulfonyl derivative as RHO kinase inhibitor
US9877957B2 (en) * 2014-09-05 2018-01-30 Merck Sharp & Dohme Corp. Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
JP6873145B2 (ja) 2016-01-14 2021-05-19 バイエル・ファルマ・アクティエンゲゼルシャフト 5−置換2−(モルホリン−4−イル)−1,7−ナフチリジン
EP3500285B1 (en) 2016-08-16 2022-04-20 Henry Ford Health System Compositions for the treatment of chemotherapy-induced neuropathic pain
WO2018057989A1 (en) * 2016-09-24 2018-03-29 Washington University INHIBITORS OF SARM1 NADase ACTIVITY AND USES THEREOF
US11098026B2 (en) * 2017-03-13 2021-08-24 Impetis Biosciences Limited Fused bicyclic compounds, compositions and applications thereof
US12448374B2 (en) 2018-06-07 2025-10-21 Disarm Therapeutics, Inc. Inhibitors of SARM1
JP7481329B2 (ja) 2018-06-07 2024-05-10 ディスアーム セラピューティクス, インコーポレイテッド Sarm1阻害剤
ES3028093T3 (en) 2018-06-07 2025-06-18 Disarm Therapeutics Inc Inhibitors of sarm1
CN109223787A (zh) 2018-10-04 2019-01-18 南京先进生物材料与过程装备研究院有限公司 一种喜树碱和新型酞嗪酮类化合物联合用药物组合物
CN109180642A (zh) 2018-10-04 2019-01-11 南京先进生物材料与过程装备研究院有限公司 酞嗪酮类btk抑制剂及其应用
CN109293635A (zh) 2018-10-04 2019-02-01 南京先进生物材料与过程装备研究院有限公司 一种新型btk激酶抑制剂的p晶型及其制备方法
CN109336863A (zh) 2018-10-04 2019-02-15 南京先进生物材料与过程装备研究院有限公司 一种新型酞嗪酮类btk抑制剂、制备及其应用
CN109485636A (zh) 2018-10-04 2019-03-19 南京先进生物材料与过程装备研究院有限公司 一种新型btk激酶抑制剂的盐酸盐及其制备方法与用途
US20220072019A1 (en) 2018-10-19 2022-03-10 Disarm Therapeutics, Inc. Inhibitors of sarm1 in combination with nad+ or a nad+ precursor
CN109172562A (zh) 2018-10-31 2019-01-11 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和甲氧基酞嗪酮类btk抑制剂联合用药物组合物及其应用
CN109331018A (zh) 2018-10-31 2019-02-15 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和硝基酞嗪酮btk抑制剂联合用药物组合物及其应用
CN109394766A (zh) 2018-10-31 2019-03-01 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和对苯硝基酞嗪酮类btk抑制剂联合用药物组合物及其应用
CN109276571A (zh) 2018-10-31 2019-01-29 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和新型硝基酞嗪酮btk抑制剂联合用药物组合物及其应用
CN109481441A (zh) 2018-10-31 2019-03-19 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和新型甲氧基酞嗪酮类btk抑制剂联合用药物组合物及其应用
WO2021261540A1 (ja) 2020-06-25 2021-12-30 富士フイルム株式会社 腸管上皮細胞の製造方法、及びその利用

Similar Documents

Publication Publication Date Title
JP2021527125A5 (https=)
JPWO2019236879A5 (https=)
JP2021528488A5 (https=)
JP2010526146A5 (https=)
JP2024050527A5 (https=)
JP2013532652A5 (https=)
RU2003133448A (ru) 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс- хемокинового рецептора
JP2007504235A5 (https=)
JP2007511504A5 (https=)
JP2001525359A5 (https=)
JP2005505506A5 (https=)
JP2006507220A5 (https=)
JP2006507355A5 (https=)
JPWO2023195529A5 (https=)
JP2020511536A5 (https=)
JPWO2022251502A5 (https=)
JP2005530779A5 (https=)
JP2004525183A5 (https=)
JP7416757B2 (ja) 置換テトラヒドロシクロペンタ[c]ピロール、置換ジヒドロピロリジン、その類似体、およびそれらを使用する方法
RU2005109156A (ru) Новые соединения
JP2010514733A5 (https=)
JP2021534254A5 (ja) 心臓弁疾患を治療するための医薬組成物
JPWO2019236884A5 (https=)
JP2005514370A5 (https=)
JP2006521407A5 (https=)